Literature DB >> 23091229

Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer.

Cecilia Pompili1, Michele Salati, Majed Refai, Rossana Berardi, Azzurra Onofri, Paola Mazzanti, Alessandro Brunelli.   

Abstract

OBJECTIVES: The objective of this study was to assess the prognostic role of preoperative quality of life (QoL) in patients operated on for early-stage non-small-cell lung cancer (NSCLC).
METHODS: This is an observational analysis of 131 consecutive patients (2003-08) submitted to pulmonary lobectomy and systematic nodal dissection for pathological pT1N0 or pT2N0 stages NSCLC with a complete follow-up (median 40 months). QoL was measured by the Short Form 36v2, a multidimensional survey assessing eight domains and two composite scales (physical component score [PCS] and mental component score [MCS]). Survival was calculated by the Kaplan-Meier method. The log-rank test was used to assess differences between groups. The relationships between survival and QoL composite scales were determined by Cox proportional hazards regression analysis adjusting for the effect of several baseline and clinical variables. PCS and MCS were categorized according to their values greater or lower than 50 percentiles (general population norms).
RESULTS: Fifty-three (40%) patients had PCS <50 and 71 (54%) had MCS <50. Results from physical functioning (P = 0.03) and general health (P = 0.03) scales were directly associated with survival. Multivariable regression showed that significant factors associated with overall survival were age >70 (hazard ratio [HR] 2.4, 95% confidence interval [95% CI] 1.2-4.8, P = 0.01) and PCS <50 (HR 2.3, 95% CI 1.4-4.4, P = 0.01). MCS, pT stage, histology, forced expiratory volume in 1 s, DLCO were not associated with prognosis. Patients with PCS >50 lived longer than those with PCS <50 (5-year overall survival 79 vs 49%, P = 0.01), in both pT1 (5-year overall survival 80 vs 49%) and pT2 stages (5-year overall survival 78 vs 48%). Cancer-specific 5-year survival was better in patients with a preoperative PCS >50 compared with those with PCS <50 (89 vs 73%, P = 0.05). Deaths due to cancer recurrence were similar in patients with PCS <50 and >50 (55 vs 53%, P = 0.9).
CONCLUSIONS: The physical component of QoL was associated with overall and cancer-specific survivals in patients operated on for early-stage NSCLC. Supportive interventions aimed at improving the perception of physical well-being should be tested to verify whether they can improve long-term prognosis after lung cancer surgery.

Entities:  

Mesh:

Year:  2012        PMID: 23091229     DOI: 10.1093/ejcts/ezs532

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  12 in total

Review 1.  A systematic review of the impact of pain on overall survival in patients with cancer.

Authors:  Dylan Zylla; Grant Steele; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2017-02-11       Impact factor: 3.603

2.  The prognostic value of pre-diagnosis health-related quality of life on survival: a prospective cohort study of older Americans with lung cancer.

Authors:  Laura C Pinheiro; Timothy M Zagar; Bryce B Reeve
Journal:  Qual Life Res       Date:  2017-02-14       Impact factor: 4.147

3.  Educational Attainment and Quality of Life among Older Adults before a Lung Cancer Diagnosis.

Authors:  Rebecca M Schwartz; Kristin G Bevilacqua; Naomi Alpert; Bian Liu; Kavita V Dharmarajan; Katherine A Ornstein; Emanuela Taioli
Journal:  J Palliat Med       Date:  2019-11-08       Impact factor: 2.947

4.  Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).

Authors:  Cecilia Pompili; Kevin N Franks; Alessandro Brunelli; Yusuf S Hussain; Patricia Holch; Matthew E Callister; Jonathan M Robson; Kostas Papagiannopoulos; Galina Velikova
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Quality of life after lung resection for lung cancer.

Authors:  Cecilia Pompili
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

6.  Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.

Authors:  Mark F Berry; Chi-Fu Jeffrey Yang; Matthew G Hartwig; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2015-05-16       Impact factor: 4.330

7.  Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review.

Authors:  Kuan Liao; Tianxiao Wang; Jake Coomber-Moore; David C Wong; Fabio Gomes; Corinne Faivre-Finn; Matthew Sperrin; Janelle Yorke; Sabine N van der Veer
Journal:  BMC Cancer       Date:  2022-10-19       Impact factor: 4.638

Review 8.  Association between physical activity and patient-reported outcome measures in patients with lung cancer: a systematic review and meta-analysis.

Authors:  Peña-Perez Teba; Mur-Gimeno Esther; Sebio-García Raquel
Journal:  Qual Life Res       Date:  2022-01-21       Impact factor: 4.147

9.  Changes in exercise tolerance and quality of life are unrelated in lung cancer survivors who undergo video-assisted thoracic surgery.

Authors:  Kunihiko Anami; Jun Horie; Yoshiyasu Hirayama; Naoki Yamashita; Kenichi Ito
Journal:  J Phys Ther Sci       Date:  2018-03-02

10.  Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients.

Authors:  Jeanne A Pierzynski; Yuanqing Ye; Scott M Lippman; Maria A Rodriguez; Xifeng Wu; Michelle A T Hildebrandt
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.